Overview

A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers

Status:
Completed

Trial end date:
2011-02-03

Target enrollment:

Participant gender:

Summary

This is a study in healthy adult volunteers to assess the bioequivalence of over-encapsulated oseltamivir capsules to commercially available oseltamivir capsules. Both formulations will be administered in the fasting state.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Oseltamivir